Thought Leadership
Email Page
Quest Integrity v. Cokebusters Puts Cloud-Based Medical Diagnostic Patents at Risk of On-Sale Bar
February 7, 2020
Matthew Murphy and David Ludwig
Medical Device and Diagnostic Industry

Axinn counsel Matthew Murphy and associate David Ludwig authored the Medical Device and Diagnostic Industry article, "Quest Integrity v. Cokebusters Puts Cloud-Based Medical Diagnostic Patents at Risk of On-Sale Bar."

Click here to access the article.